Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

High materiality8/10

Alkermes Q1 Results Beat Expectations, EPS Guidance Improved

May 6, 2026, 2:17 PM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Beating estimates generally indicates positive momentum, potentially leading to upward price adjustments in ALKS shares. Historical trends show that earnings beats often result in subsequent recovery in share price.

AI summary

What happened, with direct paths to the underlying reporting

Alkermes exceeded Q1 earnings projections with a loss of 40 cents per share and strong sales of nearly $393 million, leading to a raise in FY2026 EPS guidance. Despite a 2.6% drop in stock price post-announcement, analysts have increased price targets, indicating ongoing investor confidence.

ALKS reported Q1 losses of 40 cents per share, beating expectations.
Sales of $392.911 million exceeded analyst expectations of $359.848 million.
FY2026 GAAP EPS guidance raised from $(0.80)-(0.68) to $(0.52)-(0.41).
Stock price fell 2.6% to $35.30 post-results announcement.
Analysts from Needham and Wells Fargo raised their price targets for ALKS.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Alkermes Q1 Results Beat Expectations, EPS Guidance Improved

Alkermes Surges After Positive LUMRYZ Study Results and Analyst Upgrades

Alkermes classified as overbought, raising caution for momentum investors

Alkermes raises offer for Avadel after Lundbeck bid

Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal